ClinicalTrials.Veeva

Menu

Effect of Acetazolamide & Position in CSF Leakage and Collection and Wound Dehiscence

T

Tehran University of Medical Sciences

Status and phase

Unknown
Phase 2

Conditions

Split Cord Malformation
Lipomyelomeningocele
Tumor
Fibrolipoma of Filum Terminale
Tethered Cord Syndrome
Dermal Sinus

Treatments

Other: Acetazolamide+ prone positioning
Drug: Acetazolamide
Other: prone positioning

Study type

Interventional

Funder types

Other

Identifiers

NCT01867268
21843 (Other Identifier)
2137

Details and patient eligibility

About

  • Purpose of study : to determine the preventive effect of acetazolamide administration, prone positioning, and the combination of both following the neurosurgical interventions in lumbosacral region for cerebrospinal fluid (CSF) leak, CSF collection and wound dehiscence.

  • Sample size: 144

  • intervention groups:

    • Group A: Acetazolamide administration for 10 days
    • Group B: prone positioning for 10 days
    • Group C: Acetazolamide administration and prone positioning for 10 days
    • Group D: no intervention
  • Period of study: Autumn 2012 to the end of winter of 2015

Full description

The purpose of this study is to evaluate the effect of Acetazolamide administration and prone positioning following lumbosacral spinal surgery in preventing cerebro-spinal fluid leakage and collection and wound dehissence in children admitted to Children Medical Center of Tehran since Autumn 2012 to the end of winter of 2015.The study is run under 4 categories of intervention:

  • Group A: Acetazolamide administration for 10 days
  • Group B: prone positioning for 10 days
  • Group C: Acetazolamide administration and prone positioning for 10 days
  • Group D: no intervention All patients are randomly assigned to these groups and when the patients faced with any of these complications, the protocol changes to Acetazolamide administration and prone positioning and the patient is considered as the failure of the protocol.

Enrollment

144 estimated patients

Sex

All

Ages

Under 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Untethering surgery for primary tethered cord caused by thick filum
  • Lipomyelomeningocele
  • Split cord malformation management
  • Untethering surgery in uncomplicated Dermal sinus
  • Tumors needing intradural management in lumbosacral region
  • Having any other disease with similar management technique

Exclusion criteria

  • Infected dermoid tumors
  • Intramedullary abscess
  • Myelomeningocele surgery and related reoperation
  • Meningocele
  • Presence of hydrocephalus

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

144 participants in 4 patient groups

Acetazolamide
Experimental group
Description:
administration of Acetazolamide for 10 days following the surgery
Treatment:
Drug: Acetazolamide
Control
No Intervention group
Description:
control group without any intervention
Prone positioning
Experimental group
Description:
Positioning the patient following surgery for 10 days
Treatment:
Other: prone positioning
Acetazolamide and Prone positioning
Experimental group
Description:
applying both Acetazolamide and prone positioning
Treatment:
Other: Acetazolamide+ prone positioning

Trial contacts and locations

1

Loading...

Central trial contact

Farideh Nejat, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems